A clinical trial evaluating pharmacist-guided self-management of hypertension among veterans with CKD, rationale and...

Area of Science:

• Nephrology
• Cardiology
• Pharmacology

Background:

• Chronic kidney disease (CKD) is linked to high rates of morbidity and mortality, primarily from CKD progression and cardiovascular disease (CVD).
• Effective blood pressure (BP) management is crucial for reducing CVD risk and slowing CKD progression.
• Current treatment strategies often involve limited patient engagement, with a significant number of CKD patients failing to reach their BP goals.

Purpose of the Study:

• To evaluate the effectiveness of a pharmacist-guided, patient-driven titration strategy for blood pressure medications in patients with CKD.
• To compare this novel approach against standard self-monitoring for achieving blood pressure control in a veteran population.

Main Methods:

• A randomized clinical trial involving 160 Veterans with uncontrolled hypertension and stages 2-4 CKD.
• Participants were randomized into two arms: pharmacist self-guided management or self-monitoring.
• The study duration was 12 months, employing mixed methods including clinical outcome assessments and qualitative interviews.

Main Results:

• The primary outcome was the change in standardized office systolic blood pressure at 12 months.
• Secondary outcomes included changes in diastolic BP (office and home), conventional BP measurements, and emergency room visits.
• Qualitative data explored patient acceptability, adherence, and barriers/facilitators to the self-management approach.

Conclusions:

• Pharmacist-guided, patient-driven BP management demonstrates potential for improving hypertension control in CKD patients.
• This patient-centered model may enhance adherence and offer a scalable solution for managing complex conditions like CKD.
• Further research should explore long-term outcomes and broader implementation strategies.